Characterization of ZnO:Al deposited by co-sputtering for transparent conductive electrodes

Aluminum doped zinc oxide was prepared by magnetron sputtering methods at room temperature using a ZnO ceramic target doped 2%wt by Al2O3. The optical transmittance of the films is higher than 80% in the visible range. A direct bandgap type was reached by controlling deposition conditions; the bandgap value was in the range between 3.2 eV and 4.2 eV. Good electrical and optical properties were obtained for the films deposited by an appropriate co-sputtering of ZnO and Al targets. These films with a resistivity, about 1.3´10-2W.cm, and a transmittance, higher than 80%, can be applicable for transparent conducting electrodes

Fabrication of Organolead Iodide Perovskite Solar Cells with Niobium-doped Titanium Dioxide as Compact Layer

Organometal halide perovskite materials have shown high potential as light absorbers for photovoltaic applications. In this work, perovskite planar solar cells were fabricated on corning substrates with the structure as follows: the first layer made of tantalum-doped tin oxide as transparent contact material, followed by sputtering niobium-doped titanium oxide as the compact electron transport layer; covered with perovskite CH3NH3PbI3 as the light harvester by combination between spin-coating and dipping methods; CuSCN was evaporated as the hole transport layer; the final thin Al/Ag electrodes were deposited. This configuration is shortly described as Al/TTO/NTO/CH3NH3PbI3/CuSCN/Ag. Such heterojunctions are expected to be suitable for the development of efficient hybrid solar cells. The fabricated cells were measured under the air mass 1.5 illumination condition, showed the rectification effect and exhibited a power conversion efficiency of 0.007%, with a open circuit voltage of 53.2 mV, a short circuit current of 0.36 mA/cm2, and a form factor of 37%. The power conversion efficiency will be further optimized in near future

SIP-MBA: A secure IoT platform with brokerless and micro-service architecture

The Internet of Things is one of the most interesting technology trends today. Devices in the IoT network are often geared towards mobility and compact in size, thus having a rather weak hardware configuration. There are many light weight protocols, tailor-made suitable for limited processing power and low energy consumption, of which MQTT is the typical one. The current MQTT protocol supports three types of quality-of-service (QoS) and the user has to trade-off the security of the packet transmission by transmission rate, bandwidth and energy consumption. The MQTT protocol, however, does not support packet storage mechanisms which means that when the receiver is interrupted, the packet cannot be retrieved. In this paper, we present a broker-less SIP-MBA Platform, designed for micro-service and using gRPC protocol to transmit and receive messages. This design optimizes the transmission rate, power consumption and transmission bandwidth, while still meeting reliability when communicating. Besides, we implement users and things management mechanisms with the aim of improving security issues. Finally, we present the test results by implementing a collect data service via gRPC protocol and comparing it with streaming data by using the MQTT protocol.Web of Science12759358

IoHT-MBA: An Internet of Healthcare Things (IoHT) platform based on microservice and brokerless architecture

Internet of Thing (IoT), currently, is one of the technology trends that are most interested. IoT can be divided into five main areas including: Health-care, Environmental, Smart city, Commercial and Industrial. The IoHT-MBA Platform is considered the backbone of every IoT architecture, so the optimal design of the IoHT-MBA Platform is essential issue, which should be carefully considered in the different aspects. Although, IoT is applied in multiple domains, however, there are still three main features that are challenge to improve: i) data collection, ii) users, devices management, and iii) remote device control. Today's medical IoT systems, often too focused on the big data or access control aspects of participants, but not focused on collecting data accurately, quickly, and efficiently; power redundancy and system expansion. This is very important for the medical sector - which always prioritizes the availability of data for therapeutic purposes over other aspects. In this paper, we introduce the IoHT Platform for Healthcare environment which is designed by microservice and brokerless architecture, focusing strongly on the three aforementioned characteristics. In addition, our IoHT Platform considers the five other issues including (1) the limited processing capacity of the devices, (2) energy saving for the device, (3) speed and accurate of the data collection, (4) security mechanisms and (5) scalability of the system. Also, in order for the IoHT Platform to be suitable for the field of health monitoring, we also add realtime alerts for the medical team. In the evaluation section, moreover, we describe the evaluation to prove the effectiveness of the proposed IoHT Platform (i.e. the proof-of-concept) in the performance, non-error, and non affected by geographical distance. Finally, a complete code solution is publicized on the authors' GitHub repository to engage further reproducibility and improvement.Web of Science12760159

Ventilator-associated respiratory infection in a resource-restricted setting: impact and etiology.

BACKGROUND: Ventilator-associated respiratory infection (VARI) is a significant problem in resource-restricted intensive care units (ICUs), but differences in casemix and etiology means VARI in resource-restricted ICUs may be different from that found in resource-rich units. Data from these settings are vital to plan preventative interventions and assess their cost-effectiveness, but few are available. METHODS: We conducted a prospective observational study in four Vietnamese ICUs to assess the incidence and impact of VARI. Patients ≥ 16 years old and expected to be mechanically ventilated > 48 h were enrolled in the study and followed daily for 28 days following ICU admission. RESULTS: Four hundred fifty eligible patients were enrolled over 24 months, and after exclusions, 374 patients' data were analyzed. A total of 92/374 cases of VARI (21.7/1000 ventilator days) were diagnosed; 37 (9.9%) of these met ventilator-associated pneumonia (VAP) criteria (8.7/1000 ventilator days). Patients with any VARI, VAP, or VARI without VAP experienced increased hospital and ICU stay, ICU cost, and antibiotic use (p < 0.01 for all). This was also true for all VARI (p < 0.01 for all) with/without tetanus. There was no increased risk of in-hospital death in patients with VARI compared to those without (VAP HR 1.58, 95% CI 0.75-3.33, p = 0.23; VARI without VAP HR 0.40, 95% CI 0.14-1.17, p = 0.09). In patients with positive endotracheal aspirate cultures, most VARI was caused by Gram-negative organisms; the most frequent were Acinetobacter baumannii (32/73, 43.8%) Klebsiella pneumoniae (26/73, 35.6%), and Pseudomonas aeruginosa (24/73, 32.9%). 40/68 (58.8%) patients with positive cultures for these had carbapenem-resistant isolates. Patients with carbapenem-resistant VARI had significantly greater ICU costs than patients with carbapenem-susceptible isolates (6053 USD (IQR 3806-7824) vs 3131 USD (IQR 2108-7551), p = 0.04) and after correction for adequacy of initial antibiotics and APACHE II score, showed a trend towards increased risk of in-hospital death (HR 2.82, 95% CI 0.75-6.75, p = 0.15). CONCLUSIONS: VARI in a resource-restricted setting has limited impact on mortality, but shows significant association with increased patient costs, length of stay, and antibiotic use, particularly when caused by carbapenem-resistant bacteria. Evidence-based interventions to reduce VARI in these settings are urgently needed

Awareness and preparedness of healthcare workers against the first wave of the COVID-19 pandemic: A cross-sectional survey across 57 countries.

BACKGROUND: Since the COVID-19 pandemic began, there have been concerns related to the preparedness of healthcare workers (HCWs). This study aimed to describe the level of awareness and preparedness of hospital HCWs at the time of the first wave. METHODS: This multinational, multicenter, cross-sectional survey was conducted among hospital HCWs from February to May 2020. We used a hierarchical logistic regression multivariate analysis to adjust the influence of variables based on awareness and preparedness. We then used association rule mining to identify relationships between HCW confidence in handling suspected COVID-19 patients and prior COVID-19 case-management training. RESULTS: We surveyed 24,653 HCWs from 371 hospitals across 57 countries and received 17,302 responses from 70.2% HCWs overall. The median COVID-19 preparedness score was 11.0 (interquartile range [IQR] = 6.0-14.0) and the median awareness score was 29.6 (IQR = 26.6-32.6). HCWs at COVID-19 designated facilities with previous outbreak experience, or HCWs who were trained for dealing with the SARS-CoV-2 outbreak, had significantly higher levels of preparedness and awareness (p<0.001). Association rule mining suggests that nurses and doctors who had a 'great-extent-of-confidence' in handling suspected COVID-19 patients had participated in COVID-19 training courses. Male participants (mean difference = 0.34; 95% CI = 0.22, 0.46; p<0.001) and nurses (mean difference = 0.67; 95% CI = 0.53, 0.81; p<0.001) had higher preparedness scores compared to women participants and doctors. INTERPRETATION: There was an unsurprising high level of awareness and preparedness among HCWs who participated in COVID-19 training courses. However, disparity existed along the lines of gender and type of HCW. It is unknown whether the difference in COVID-19 preparedness that we detected early in the pandemic may have translated into disproportionate SARS-CoV-2 burden of disease by gender or HCW type

Associations of Underlying Health Conditions With Anxiety and Depression Among Outpatients: Modification Effects of Suspected COVID-19 Symptoms, Health-Related and Preventive Behaviors

Objectives: We explored the association of underlying health conditions (UHC) with depression and anxiety, and examined the modification effects of suspected COVID-19 symptoms (S-COVID-19-S), health-related behaviors (HB), and preventive behaviors (PB).Methods: A cross-sectional study was conducted on 8,291 outpatients aged 18–85 years, in 18 hospitals and health centers across Vietnam from 14th February to May 31, 2020. We collected the data regarding participant's characteristics, UHC, HB, PB, depression, and anxiety.Results: People with UHC had higher odds of depression (OR = 2.11; p &lt; 0.001) and anxiety (OR = 2.86; p &lt; 0.001) than those without UHC. The odds of depression and anxiety were significantly higher for those with UHC and S-COVID-19-S (p &lt; 0.001); and were significantly lower for those had UHC and interacted with “unchanged/more” physical activity (p &lt; 0.001), or “unchanged/more” drinking (p &lt; 0.001 for only anxiety), or “unchanged/healthier” eating (p &lt; 0.001), and high PB score (p &lt; 0.001), as compared to those without UHC and without S-COVID-19-S, “never/stopped/less” physical activity, drinking, “less healthy” eating, and low PB score, respectively.Conclusion: S-COVID-19-S worsen psychological health in patients with UHC. Physical activity, drinking, healthier eating, and high PB score were protective factors

Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial

Background Trials of fluoxetine for recovery after stroke report conflicting results. The Assessment oF FluoxetINe In sTroke recoverY (AFFINITY) trial aimed to show if daily oral fluoxetine for 6 months after stroke improves functional outcome in an ethnically diverse population. Methods AFFINITY was a randomised, parallel-group, double-blind, placebo-controlled trial done in 43 hospital stroke units in Australia (n=29), New Zealand (four), and Vietnam (ten). Eligible patients were adults (aged ≥18 years) with a clinical diagnosis of acute stroke in the previous 2–15 days, brain imaging consistent with ischaemic or haemorrhagic stroke, and a persisting neurological deficit that produced a modified Rankin Scale (mRS) score of 1 or more. Patients were randomly assigned 1:1 via a web-based system using a minimisation algorithm to once daily, oral fluoxetine 20 mg capsules or matching placebo for 6 months. Patients, carers, investigators, and outcome assessors were masked to the treatment allocation. The primary outcome was functional status, measured by the mRS, at 6 months. The primary analysis was an ordinal logistic regression of the mRS at 6 months, adjusted for minimisation variables. Primary and safety analyses were done according to the patient's treatment allocation. The trial is registered with the Australian New Zealand Clinical Trials Registry, ACTRN12611000774921. Findings Between Jan 11, 2013, and June 30, 2019, 1280 patients were recruited in Australia (n=532), New Zealand (n=42), and Vietnam (n=706), of whom 642 were randomly assigned to fluoxetine and 638 were randomly assigned to placebo. Mean duration of trial treatment was 167 days (SD 48·1). At 6 months, mRS data were available in 624 (97%) patients in the fluoxetine group and 632 (99%) in the placebo group. The distribution of mRS categories was similar in the fluoxetine and placebo groups (adjusted common odds ratio 0·94, 95% CI 0·76–1·15; p=0·53). Compared with patients in the placebo group, patients in the fluoxetine group had more falls (20 [3%] vs seven [1%]; p=0·018), bone fractures (19 [3%] vs six [1%]; p=0·014), and epileptic seizures (ten [2%] vs two [<1%]; p=0·038) at 6 months. Interpretation Oral fluoxetine 20 mg daily for 6 months after acute stroke did not improve functional outcome and increased the risk of falls, bone fractures, and epileptic seizures. These results do not support the use of fluoxetine to improve functional outcome after stroke

UIP2SOP: A unique IoT network applying single sign-on and message queue protocol

Internet of Things (IoT), currently, plays an importance role in our life, also, this is one of the most rapidly developing technology trends. However, the present structure has some limitation - one of these is the communication via clientserver model - the users, devices, and applications using IoT services where all the connection/requirement is managed at IoT service providers. On the one hand, the IoT service providers (e.g., individual, organization) have different method to manage their devices, services, and users. Thus, the unique standard (i.e., communication method among the service providers and between client server) is still the challenge for the developers. On the other hand, Message Queuing Telemetry Protocol (MQTT) that is one of the most popular protocols in IoT deployments, has significant security and privacy issues by itself (e.g., authentication, authorization, as well as privacy problem). Therefore, this paper proposes UIP2SOP - an unique IoT network by using Single SignOn (SSO) and message queue to improve the MQTT protocol's security problem. Besides, this model allows the organizations to provide the IoT services to connect into a single network but does not change the architecture of organization at all. The evaluation section proves the effectiveness of our proposed model. In particular, we consider the number of concurrent users publishing messages simultaneously in the two scenarios i) internal communication and ii) external communication. In addition, we evaluate recovery ability of system when occurred broken connection. Finally, to engage further reproducibility and improvement, we share a complete code solution is publicized on the GitHub repository.Web of Science126301